Unofin Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Chandigarh, Chandigarh, India, established in 2010.
2010 Chandigarh, Chandigarh, India Struck Off
Last Updated:
About Unofin Pharmaceuticals Private Limited

Unofin Pharmaceuticals Private Limited, a struck off private limited company, was established on 13 August 2010 in Chandigarh, Chandigarh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232CH2010PTC032398. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ganesh Chandra Bhatt (Director), Sameer Raturi (Director). Its latest AGM occurred on 24 September 2013, with the balance sheet filed on 31 March 2013. It is based at House No. 564, Sector 22A, Chandigarh, Chandigarh, 160022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232CH2010PTC032398

  • Registration Number

    032398

  • Incorporation Date

    13 August 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chandigarh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 6 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Unofin Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unofin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Unofin Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ganesh Chandra Bhatt Director 13 Aug 2010 Current
Sameer Raturi Director 13 Aug 2010 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unofin Pharmaceuticals.

Enhance accessibility to Unofin Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Unofin Pharmaceuticals revenue growth over time
Unofin Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unofin Pharmaceuticals?

Unlock access to Unofin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Unofin Pharmaceuticals?

Unlock and access historical data on people associated with Unofin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unofin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unofin Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unofin Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Unofin Pharmaceuticals Private Limited last Annual general meeting of members was held on 24 Sep 2013 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Unofin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Chandigarh. was documented.

  • Director Appointment

    Ganesh Chandra Bhatt was appointed as a Director was appointed as a Director on 13 Aug 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.

  • Director Appointment

    Sameer Raturi was appointed as a Director was appointed as a Director on 13 Aug 2010 & has been associated with this company since 15 years 6 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Unofin Pharmaceuticals Private Limited was registered on 13 Aug 2010 with Roc Chandigarh & aged 15 years 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unofin Pharmaceuticals Private Limited?

The CIN of Unofin Pharmaceuticals Private Limited is U24232CH2010PTC032398.

Where is Unofin Pharmaceuticals Private Limited headquartered?

Unofin Pharmaceuticals Private Limited is headquartered at House No. 564, Sector 22A, Chandigarh, Chandigarh, 160022.

When was Unofin Pharmaceuticals Private Limited incorporated?

Unofin Pharmaceuticals Private Limited was incorporated on 13 August 2010.

Who are the current directors of Unofin Pharmaceuticals Private Limited?

The current directors of Unofin Pharmaceuticals Private Limited are

What is the primary industry of Unofin Pharmaceuticals Private Limited?

The primary industry of Unofin Pharmaceuticals Private Limited is Chemicals.

Is Unofin Pharmaceuticals Private Limited a listed company?

Unofin Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Unofin Pharmaceuticals Private Limited?

The authorized capital of Unofin Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available